Article: Bolli, R., et al. (2020). “Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients.” JACC: CardioOncology 2(4): 581-595.
Presenter: Kristine Jang, MD cardio-oncology fellow Kettering Cancer Center – New York, NY, USA